How many stocks are there of Polynovo?
The current number of stocks of Polynovo is 700.38 M undefined.
Polynovo Stocks 2024
Polynovo Stocks
700.38 M
Ticker
PNV.AX
ISIN
AU000000PNV0
WKN
A12F4T
In 2024, Polynovo had 700.38 M outstanding stocks, a 2.33% change from the 684.45 M stocks in the previous year.
The Polynovo Stocks history
| YEAR | NUMBER OF STOCKS (undefined AUD) |
|---|---|
| 2030e | 700.38 |
| 2029e | 700.38 |
| 2028e | 700.38 |
| 2027e | 700.38 |
| 2026e | 700.38 |
| 2025e | 700.38 |
| 2024 | 700.38 |
| 2023 | 684.45 |
| 2022 | 660.87 |
| 2021 | 661.19 |
| 2020 | 661.09 |
| 2019 | 659.66 |
| 2018 | 627.89 |
| 2017 | 561.76 |
| 2016 | 493.26 |
| 2015 | 418.51 |
| 2014 | 410.94 |
| 2013 | 347.48 |
| 2012 | 346.63 |
| 2011 | 346.63 |
| 2010 | 320.64 |
| 2009 | 301.45 |
| 2008 | 300.95 |
| 2007 | 293.14 |
| 2006 | 261.3 |
| 2005 | 230.11 |
Polynovo shares outstanding AU000000PNV0 · A12F4T
The number of shares was Polynovo in 2023 — This indicates how many shares 684.454 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Polynovo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Polynovo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Polynovo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Polynovo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 230.11 M Aktien |
| 2006 | 261.3 M Aktien |
| 2007 | 293.14 M Aktien |
| 2008 | 300.95 M Aktien |
| 2009 | 301.45 M Aktien |
| 2010 | 320.64 M Aktien |
| 2011 | 346.63 M Aktien |
| 2012 | 346.63 M Aktien |
| 2013 | 347.48 M Aktien |
| 2014 | 410.94 M Aktien |
| 2015 | 418.51 M Aktien |
| 2016 | 493.26 M Aktien |
| 2017 | 561.76 M Aktien |
| 2018 | 627.89 M Aktien |
| 2019 | 659.66 M Aktien |
| 2020 | 661.09 M Aktien |
| 2021 | 661.19 M Aktien |
| 2022 | 660.87 M Aktien |
| 2023 | 684.45 M Aktien |
| 2024 | 700.38 M Aktien |
| 2025e | 700.38 M Aktien |
| 2026e | 700.38 M Aktien |
| 2027e | 700.38 M Aktien |
| 2028e | 700.38 M Aktien |
| 2029e | 700.38 M Aktien |
| 2030e | 700.38 M Aktien |
Polynovo Aktienanalyse
What does Polynovo do?
Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Polynovo's Shares Outstanding
Polynovo's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Polynovo’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Polynovo’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Polynovo’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Polynovo stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Polynovo are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Polynovo evolved in recent years?
The number of shares of Polynovo has increased by 2.33% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Polynovo as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Polynovo?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Polynovo pay?
Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.
What is the dividend yield of Polynovo?
The current dividend yield of Polynovo is .
When does Polynovo pay dividends?
Polynovo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Polynovo?
Polynovo paid dividends every year for the past 0 years.
What is the dividend of Polynovo?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Polynovo located?
Polynovo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Polynovo from 10/21/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.
When did Polynovo pay the last dividend?
The last dividend was paid out on 10/21/2024.
What was the dividend of Polynovo in the year 2023?
In the year 2023, Polynovo distributed 0 AUD as dividends.
In which currency does Polynovo pay out the dividend?
The dividends of Polynovo are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Polynovo
Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
